| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Eton Pharmaceuticals, Inc. (ETON) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. ETON is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.67M | $123.07M | -28,315 | |
| CEO | 1.06M | $49.01M | - | |
| Other | 630.2K | $29.10M | - | |
| Dir | 295.2K | $13.63M | - | |
| Dir | 286.5K | $13.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2018 | Casamento Charles J71 | Director | Buy | 5,000 | $6.00 | $30,000.00 | +7.9% |